Viant Technology Inc. (NASDAQ:DSP – Get Free Report) CFO Larry Madden sold 3,084 shares of Viant Technology stock in a transaction that occurred on Monday, September 23rd. The stock was sold at an average price of $11.05, for a total value of $34,078.20. Following the sale, the chief financial officer now directly owns 538,434 shares of the company’s stock, valued at $5,949,695.70. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Larry Madden also recently made the following trade(s):
- On Friday, September 20th, Larry Madden sold 1,116 shares of Viant Technology stock. The shares were sold at an average price of $11.02, for a total transaction of $12,298.32.
Viant Technology Stock Up 1.0 %
Shares of DSP traded up $0.11 during midday trading on Tuesday, hitting $11.18. The company’s stock had a trading volume of 61,536 shares, compared to its average volume of 128,302. Viant Technology Inc. has a one year low of $4.98 and a one year high of $12.36. The company’s fifty day simple moving average is $10.70 and its two-hundred day simple moving average is $10.01. The stock has a market capitalization of $709.87 million, a price-to-earnings ratio of -92.00 and a beta of 0.74.
Analysts Set New Price Targets
A number of analysts have recently weighed in on the company. Canaccord Genuity Group reiterated a “hold” rating and set a $11.00 target price on shares of Viant Technology in a research report on Tuesday, August 13th. Needham & Company LLC reiterated a “buy” rating and set a $12.00 price objective on shares of Viant Technology in a research note on Tuesday, August 13th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $11.80.
Check Out Our Latest Research Report on DSP
Institutional Investors Weigh In On Viant Technology
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. ClariVest Asset Management LLC acquired a new position in Viant Technology during the 2nd quarter worth about $1,387,000. Acadian Asset Management LLC lifted its holdings in Viant Technology by 659.4% during the 2nd quarter. Acadian Asset Management LLC now owns 142,384 shares of the company’s stock worth $1,403,000 after buying an additional 123,635 shares during the period. Federated Hermes Inc. lifted its holdings in Viant Technology by 5,286.9% during the 2nd quarter. Federated Hermes Inc. now owns 67,767 shares of the company’s stock worth $669,000 after buying an additional 66,509 shares during the period. G2 Investment Partners Management LLC lifted its holdings in Viant Technology by 11.6% during the 4th quarter. G2 Investment Partners Management LLC now owns 430,850 shares of the company’s stock worth $2,969,000 after buying an additional 44,779 shares during the period. Finally, AQR Capital Management LLC acquired a new position in Viant Technology during the 2nd quarter worth about $236,000. Institutional investors own 11.38% of the company’s stock.
Viant Technology Company Profile
Viant Technology Inc operates as an advertising technology company. It provides Household ID, a people-based innovation that combines digital and personal identifiers into a normalized household profile; AI Bid Optimizer, solution that uses AI to analyze historical bid opportunities to predict the lowest media cost for desired advertisement; and Viant Data Platform, which offers marketers control over their own data with actionable insights into their marketing initiatives within a single platform.
Further Reading
- Five stocks we like better than Viant Technology
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What are earnings reports?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is a Low P/E Ratio and What Does it Tell Investors?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Viant Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viant Technology and related companies with MarketBeat.com's FREE daily email newsletter.